Cytomyx Share Discussion Threads

[zinyowem] 30/3/2004 08:32

Took a long term view on these. Nothing has changed for me. Just annoyed didn't top up again at the low offer of 22p. Still early days though...will be interesting to see where it ends today, but not being drawn in again, still happy with what i am holding.

[bernieboy] 30/3/2004 08:01

I reckon that those who have sold out recently especially at around 18p will be pretty gutted today ! I have been waiting on the sidelines with a view to getting back in - lost my bottle and didn't take the plunge. What could it get to today ???

[zinyowem] 29/3/2004 15:56

Things looking nasty.....18 - 22p........mmm

[phacops] 24/3/2004 10:10

Being marked down again this morning with no trades as yet. Their CEO said in Shares mag that they will post another loss, yet again, with the final results in June. With the loss of Molecular Probes (a sizeable portion of CB's sales) and huge cash burn, will they even make it to June?

[ok,yah] 17/3/2004 21:17

ajrice,

Not really market manipulation

This happens with thinly traded small cap stocks - market makers don't like to accumulate stock when buying interest seems to disappear (in case of worst case scenario) and walk the price down as long as sellers and buyers are roughly matched.

Until for whatever reason buyers come back in this will continue to fall.

Of course as volumes have been low it wont take that much buying to start reversing the share price losses.

[ajrice] 16/3/2004 10:33

Can anyone explain to me why CYX has fallen by nearly 40% in a month on the back of very thin trading and no company news? Is this not just a case of mm manipulation to frighten shareholders into large volume selling. If indeed it is, it certainly hasn't succeeded. Unless there is something they know which we don't, I would expect a mirror image of rises in the coming days/weeks. All imho., dyor.

[zinyowem] 15/3/2004 15:02

I see it but don't believe the way this has gone. Anyway time to rethink and get back to doing some work. My 22p has gone easily which makes me think all in my humble opinion ofcourse, that we could drift lower still....don't ask me where to.

[snookered4] 15/3/2004 12:48

Shut up shop Brad - this is going under. I've taken my hefty loss thanks to those friendly chaps at City Equities and put it into something with at least a glimmer of hope of making money.

[ajrice] 15/3/2004 10:16

........ and after the shake out; well mms it's all just a bit too predictable
imho.
aj.

[zinyowem] 10/3/2004 10:09

Brad44...Good luck whatever you decide.

[brad44] 10/3/2004 08:51

Cheers Zinyowem, I'm sitting on a hefty loss at the moment post consolidation, not too sure if I should average down or shut up shop and pile in to something else.. some good opportunities around at the moment!!! all the best B

[zinyowem] 09/3/2004 20:06

Brad44 - Learning charts and also some gut instinct. Have made on these, on and off before consolidation, but am down post consolidation (luckily small holding). As far as i am concerned business is making progress and acquisitions seem the way forward but in terms of price....seems to have broken support level..of 25p mid.....so for me it is a waiting game.

Nothing has changed but something is going on to hold this share back and
loads being panicked into selling. Personally waiting till next set of results, but if it breaks 22 mid then i am going to get worried....and have to consider next steps to take which will be average down (top up)..activate stop loss, or go through my research again to find out if i missed anything. But hey this is my own style...but as you can see still not confident in topping up till it settles...don't ask me where. Do your own research etc, all my own opinions. Good Luck.

[brad44] 09/3/2004 17:33

Zinyowem, what do you forsse for this share? the consolidation and now the stagnant state, do you watch charts or is there something in the pipeline?

[zinyowem] 09/3/2004 15:35

23 - 25p....Not looking good and for me, still not worth topping up....Getting tempted though.

[zinyowem] 02/3/2004 09:53

Not yet for me.

[ejones65] 26/2/2004 23:26

have rising accordingly worth topping up.

[zinyowem] 26/2/2004 11:07

Well looks like it is unable to hold. Anyway was not tempted to top up.

[zinyowem] 26/2/2004 09:27

Well article in shares mag today

Cytomyx: an oasis in a deserted fen

During the dot.com boom, Cambridge, with its array of biotech and technology start-ups, was dubbed Silicon Fen. Nowadays, according to Cytomyx's (AIM:CYX) chief executive Mike Kerins, the university town's business community looks more like Forgotten Fen.

'Cambridge looks like a ghost town,' he admits. 'Acambis (ACM) has shut down [its research laboratories], and Xenova (XEN) and Millennium Pharmaceuticals have gone. Biotech has been hammered and Cambridge has been hard hit.'

However despite being based in Cambridge's now lonely technology park, Cytomyx, a contract manufacturer for the pharmaceutical industry, is upbeat about the future. The key to Kerins's strategy has been focusing on pharmaceutical clients and away from the riskier biotechs.

'From this perspective to make the decision to get closer to big pharma has dramatically influenced our fortunes,' he says. 'Big pharma carries on spending and will be there for the longer-term perspective. We've become a product company – a developer of research tools rather than a biotech. We come from a very service-led environment and we have a much more sustainable business as a result.'

The company, with a market capitalisation of £12 million, consists of four businesses: life sciences reagent distributor Cambridge Bioscience, DNA probe technology business Cytocell, cell line production business Cytomyx Holdings and US-based tissue sample biorepository Clinomics.

Acquired in December, Clinomics has a collection of more than 200,000 samples gathered ethically from patients with many forms and stages of cancer, heart disease and neurological conditions.

The division has developed a tissue microarray – hundreds of individual tissue samples on one tiny slide allowing pharmaceutical clients to test the efficacy of new drug compounds on a range of diseases and patient types at once.

'What we've got is a pick and mix,' says Kerins. 'A huge collection in which you can be really precise in what to look for. Pharmaceutical companies are looking for absolute precision. They want 50 patients that don't respond to the drug. The answer lies in the genes and the way in which the patients are constructed.'

Shares reached a year high of 37p in January but have since trickled down to 29p. The company consolidated its share capital in December and raised £1.9 million gross through an institutional share placing. The funds are to provide working capital for investment in new products and sales and marketing. Due to the acquisition, Cytomyx will now not reach profitability until 2005.

'The reason is the investment in Clinomics,' Kerins explains. 'It's a great resource but was run on a shoestring and needs to scale up its commercial efforts. We need to put some bodies in. It's a phenomenon that has the potential to explode.'

In the year ending September 2003 Cytomyx had turnover of £5.1 million and made a pre-tax loss of £298,000. Howard Miller, analyst at house broker Teather & Greenwood, forecasts sales of £8 million and a break-even pre-tax profit of £16,000 for 2004, rising to turnover of £10 million and a £1.2 million profit in 2005.

On a price earnings ratio of 11.6 for 2005, the shares look a bargain.

[czar] 23/2/2004 15:17

T&G said strong buy at 31p, they hit 24p this morning, off 3p, suddenly up 0.5p, could this be the turning point? I hope so.

[propane] 23/2/2004 10:41

Well, that's back to 1p per share pre consolidation, plenty of room for more downside yet!!


------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
propane - 16 Jan'04 - 12:38 - 486 of 528 edit


I'm not trying to 'deramp' these but,as i said in an earlier post, i am very wary of consolidations, leaves an awful lot more 'downside' room as is being witnessed.
------------------------------------------------------------------------------------------------------------------------_____________________________________________________________________

[phacops] 20/2/2004 23:52

Zinyowem, to predict the future let's look at the past for Cytomyx...

May 2001: Raise as much cash as the company can get based on massively optomistic outlook.

December 2002. We have spent nearly all of our money in less than a year. Let's issue some more shares!

March 2003. We have spent nearly all of our money in less than 4 months. Let's issue some more shares!

December 2003. We have spent nearly all of our money in less than 10 months. Let's issue some more shares!

If i was on the board of this company I would be laughing at you all now. But I am not, just someone who likes to research companies thoroughly before investing in them, looking for value/recovery shares. I started this with Cytomyx a few months ago and posted my results then.

I believe that the true value is between 5 - 8 pence/share. Remember that at one point Alan Seely (Director) had to put up his house as capital to convince the bank that the whole company was a "going concern" and not bankrupt!

I am not qualified to give anyone advice about investments. I just research companies well, as should everyone...the information is out there.

Phacops.

[zinyowem] 19/2/2004 13:28

Now what? 27 - 28

[ozgem] 11/2/2004 14:28

Sure it will Brad, much much more to come from them.Got 1mil and sitting tight for a while on those.See you over at CFP.

[brad44] 11/2/2004 14:20

Hi Oz,

I nearly know what you feel like! I am sitting on a paper loss and at present & it hurts too much to sell!

I am in on cfp also, lets hope the upward trend can continue.

Regards
B